Home / Cancer and immune system / Pertuzumab and Trastuzumab
ATC L01FY01 · Combinations of Monoclonal Antibodies and Antibody Drug Conjugates · updated 2 Nov 2026
Pertuzumab and Trastuzumab shortage
As of 2 Nov 2026, Pertuzumab and Trastuzumab has a reported shortage in 1 of the 16 countries we track (Canada), covering 1 product from 1 company.
Is there a Pertuzumab and Trastuzumab shortage?
Yes. As of 2 Nov 2026, Pertuzumab and Trastuzumab is reported short in 1 of the 16 countries we track: Canada. The earliest expected return is 30 Nov 2026 (Canada).
Which companies are short
products short, all countriesListed: Roche ROG · SIX Swiss
Affected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | PERJETA-HERCEPTIN (1 vial of 420 mg/ 14 mL Vial (Perjeta) + 1 vial of 440 mg Vial (Herceptin)") discontinuation | HOFFMANN-LA ROCHE LIMITED | not given | 30 Nov 2026 | Not stated |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.
Questions
Is there a Pertuzumab and Trastuzumab shortage?
Yes. As of 2 Nov 2026, Pertuzumab and Trastuzumab is reported short in 1 of the 16 countries we track: Canada. The earliest expected return is 30 Nov 2026 (Canada).
When will Pertuzumab and Trastuzumab be back in stock?
Companies expect supply back from 30 Nov 2026 in Canada; Canada: 30 Nov 2026. These are company estimates reported to each authority.
Why is Pertuzumab and Trastuzumab in short supply?
The most common reason reported is: not stated. Reasons by product are listed in the table below.
Which companies have Pertuzumab and Trastuzumab shortages?
Roche.